Cargando…
A new generation of pPRIG-based retroviral vectors
BACKGROUND: Retroviral vectors are valuable tools for gene transfer. Particularly convenient are IRES-containing retroviral vectors expressing both the protein of interest and a marker protein from a single bicistronic mRNA. This coupled expression increases the relevance of tracking and/or selectio...
Autores principales: | , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241607/ https://www.ncbi.nlm.nih.gov/pubmed/18053131 http://dx.doi.org/10.1186/1472-6750-7-85 |
_version_ | 1782150519607787520 |
---|---|
author | Albagli-Curiel, Olivier Lécluse, Yann Pognonec, Philippe Boulukos, Kim E Martin, Patrick |
author_facet | Albagli-Curiel, Olivier Lécluse, Yann Pognonec, Philippe Boulukos, Kim E Martin, Patrick |
author_sort | Albagli-Curiel, Olivier |
collection | PubMed |
description | BACKGROUND: Retroviral vectors are valuable tools for gene transfer. Particularly convenient are IRES-containing retroviral vectors expressing both the protein of interest and a marker protein from a single bicistronic mRNA. This coupled expression increases the relevance of tracking and/or selection of transduced cells based on the detection of a marker protein. pAP2 is a retroviral vector containing eGFP downstream of a modified IRES element of EMCV origin, and a CMV enhancer-promoter instead of the U3 region of the 5'LTR, which increases its efficiency in transient transfection. However, pAP2 contains a limited multicloning site (MCS) and shows weak eGFP expression, which previously led us to engineer an improved version, termed pPRIG, harboring: i) the wild-type ECMV IRES sequence, thereby restoring its full activity; ii) an optimized MCS flanked by T7 and SP6 sequences; and iii) a HA tag encoding sequence 5' of the MCS (pPRIG HAa/b/c). RESULTS: The convenience of pPRIG makes it a good basic vector to generate additional derivatives for an extended range of use. Here we present several novel pPRIG-based vectors (collectively referred to as PRIGs) in which : i) the HA tag sequence was inserted in the three reading frames 3' of the MCS (3'HA PRIGs); ii) a functional domain (ER, VP16 or KRAB) was inserted either 5' or 3' of the MCS (« modular » PRIGs); iii) eGFP was replaced by either eCFP, eYFP, mCherry or puro-R (« single color/resistance » PRIGs); and iv) mCherry, eYFP or eGFP was inserted 5' of the MCS of the IRES-eGFP, IRES-eCFP or IRES-Puro-R containing PRIGs, respectively (« dual color/selection » PRIGs). Additionally, some of these PRIGs were also constructed in a pMigR MSCV background which has been widely used in pluripotent cells. CONCLUSION: These novel vectors allow for straightforward detection of any expressed protein (3'HA PRIGs), for functional studies of chimeric proteins (« modular » PRIGs), for multiple transductions and fluorescence analyses of transduced cells (« single color/resistance » PRIGs), or for quantitative detection of studied proteins in independently identified/selected transduced cells (« dual color/selection » PRIGs). They maintain the original advantages of pPRIG and provide suitable tools for either transient or stable expression and functional studies in a large range of experimental settings. |
format | Text |
id | pubmed-2241607 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-22416072008-02-13 A new generation of pPRIG-based retroviral vectors Albagli-Curiel, Olivier Lécluse, Yann Pognonec, Philippe Boulukos, Kim E Martin, Patrick BMC Biotechnol Methodology Article BACKGROUND: Retroviral vectors are valuable tools for gene transfer. Particularly convenient are IRES-containing retroviral vectors expressing both the protein of interest and a marker protein from a single bicistronic mRNA. This coupled expression increases the relevance of tracking and/or selection of transduced cells based on the detection of a marker protein. pAP2 is a retroviral vector containing eGFP downstream of a modified IRES element of EMCV origin, and a CMV enhancer-promoter instead of the U3 region of the 5'LTR, which increases its efficiency in transient transfection. However, pAP2 contains a limited multicloning site (MCS) and shows weak eGFP expression, which previously led us to engineer an improved version, termed pPRIG, harboring: i) the wild-type ECMV IRES sequence, thereby restoring its full activity; ii) an optimized MCS flanked by T7 and SP6 sequences; and iii) a HA tag encoding sequence 5' of the MCS (pPRIG HAa/b/c). RESULTS: The convenience of pPRIG makes it a good basic vector to generate additional derivatives for an extended range of use. Here we present several novel pPRIG-based vectors (collectively referred to as PRIGs) in which : i) the HA tag sequence was inserted in the three reading frames 3' of the MCS (3'HA PRIGs); ii) a functional domain (ER, VP16 or KRAB) was inserted either 5' or 3' of the MCS (« modular » PRIGs); iii) eGFP was replaced by either eCFP, eYFP, mCherry or puro-R (« single color/resistance » PRIGs); and iv) mCherry, eYFP or eGFP was inserted 5' of the MCS of the IRES-eGFP, IRES-eCFP or IRES-Puro-R containing PRIGs, respectively (« dual color/selection » PRIGs). Additionally, some of these PRIGs were also constructed in a pMigR MSCV background which has been widely used in pluripotent cells. CONCLUSION: These novel vectors allow for straightforward detection of any expressed protein (3'HA PRIGs), for functional studies of chimeric proteins (« modular » PRIGs), for multiple transductions and fluorescence analyses of transduced cells (« single color/resistance » PRIGs), or for quantitative detection of studied proteins in independently identified/selected transduced cells (« dual color/selection » PRIGs). They maintain the original advantages of pPRIG and provide suitable tools for either transient or stable expression and functional studies in a large range of experimental settings. BioMed Central 2007-11-30 /pmc/articles/PMC2241607/ /pubmed/18053131 http://dx.doi.org/10.1186/1472-6750-7-85 Text en Copyright © 2007 Albagli-Curiel et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methodology Article Albagli-Curiel, Olivier Lécluse, Yann Pognonec, Philippe Boulukos, Kim E Martin, Patrick A new generation of pPRIG-based retroviral vectors |
title | A new generation of pPRIG-based retroviral vectors |
title_full | A new generation of pPRIG-based retroviral vectors |
title_fullStr | A new generation of pPRIG-based retroviral vectors |
title_full_unstemmed | A new generation of pPRIG-based retroviral vectors |
title_short | A new generation of pPRIG-based retroviral vectors |
title_sort | new generation of pprig-based retroviral vectors |
topic | Methodology Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2241607/ https://www.ncbi.nlm.nih.gov/pubmed/18053131 http://dx.doi.org/10.1186/1472-6750-7-85 |
work_keys_str_mv | AT albaglicurielolivier anewgenerationofpprigbasedretroviralvectors AT lecluseyann anewgenerationofpprigbasedretroviralvectors AT pognonecphilippe anewgenerationofpprigbasedretroviralvectors AT boulukoskime anewgenerationofpprigbasedretroviralvectors AT martinpatrick anewgenerationofpprigbasedretroviralvectors AT albaglicurielolivier newgenerationofpprigbasedretroviralvectors AT lecluseyann newgenerationofpprigbasedretroviralvectors AT pognonecphilippe newgenerationofpprigbasedretroviralvectors AT boulukoskime newgenerationofpprigbasedretroviralvectors AT martinpatrick newgenerationofpprigbasedretroviralvectors |